Albany, NY -- (SBWire) -- 08/15/2018 --Transparency Market Research (TMR) in its latest research report on the global nonalcoholic steatohepatitis therapeutics market has observed that players within this market both new entrants as well as those established are making equal efforts to develop an enhanced and effective treatment for NASH disease. Key players operating in the market include: Gilead Sciences, Inc., Zydus Cadila, GENFIT SA, Conatus Pharmaceuticals, Intercept Pharmaceuticals Inc., Astazeneca Plc., Immuron Ltd., Galmed Pharmaceuticals Ltd., and Tobira Therapeutics, Inc. Most of the leading biopharmaceutical companies are striving to develop novel therapeutics for NASH treatment and are carrying out clinical trials. Many of the companies are based in the U.S. and are collaborating with academic institutes and research centres so as to conduct clinical trials.

Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7691

According to Transparency Market Research (TMR), the global nonalcoholic steatohepatitis therapeutics market will cross US$20.27 bn by 2025. By drug type, the demand for elafibranor is highest on account of its effectiveness in reducing the effects of the NASH disease as well as the fact that it is the most advanced drug available as of now. The second most popular drug type is obeticholic acid (OCA).

North America and Europe Remain Most Attractive Regional Markets for NASH Therapeutics

By geography, the nonalcoholic steatohepatitis therapeutics market is highly attractive in regions such as North America and Europe, as these two regions are majorly affected by NASH. The growth of this market is also associated with an increasing number of people in the region suffering from obesity and diabetes. The increasing incidences of high cholesterol as well as change in lifestyle are some of the other reasons behind the continued growth of the nonalcoholic steatohepatitis therapeutics market in these regions. High growth areas for nonalcoholic steatohepatitis therapeutics market in Europe include Germany, the U.K., Spain, Italy, and France.

Request a Sample of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7691

Appalling Cases of Obesity among a Vast Pool of Population Worldwide Continues to Fuel Demand for Effective NASH Therapeutics

The growing incidences of NASH and nonalcoholic fatty liver diseases (NAFLD) among people worldwide is behind the rise in the demand for nonalcoholic steatohepatitis therapeutics. This demand is particularly high in the developed nations of North America and Europe. Research centres are putting in much efforts for finding an effective treatment for nonalcoholic steatohepatitis disease. The growing prevalence of obesity worldwide, including obese children have created a heightened concern and need for curing the NASH disease at an early stage and keep a check on the weight. Levels of cholesterol is also high among a vast pool of population today, especially in America and this will continue to fuel the growth of the nonalcoholic steatohepatitis therapeutics market. While no exact cure exists in the market today, the treatment for NAFLD and NASH is constantly being worked upon.

As of now, there are no therapies which have been approved and thus, there is high dependency on off label agents which offer sub-optimal efficacy and safety. There are many drugs in the later stages of the pipeline and this is expected to drive the growth prospects of the market.

About Transparency Market Research
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR's syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email:sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com